Study

Recruiting Not a phased study

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Not a phased study
Sponsor Children's Oncology Group
Registry number NCT02402244
Started 3 November 2015 Today 16 October 2026 Estimated completion 31 December 2030

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
John Hunter Children's Hospital Hunter Regional Mail Centre NSW Recruiting
Sydney Children's Hospital Randwick NSW Recruiting
The Children's Hospital at Westmead Westmead NSW Recruiting
Queensland Children's Hospital South Brisbane QLD Recruiting
Women's and Children's Hospital-Adelaide North Adelaide SA Recruiting
Royal Hobart Hospital Saint Hobart TAS Suspended
Monash Medical Center-Clayton Campus Clayton VIC Recruiting
Royal Children's Hospital Parkville VIC Recruiting
Princess Margaret Hospital for Children Perth WA Active not recruiting
Perth Children's Hospital Perth WA Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age Up to 25 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 75000

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Enrollment must occur within 6 months of initial disease presentation OR within 6 months of refractory disease, disease progression, disease recurrence, second or secondary malignancy, or post-mortem

* Patients previously enrolled on ACCRN07 are eligible to enroll on Tracking Outcome, Registry and Future Contact components of APEC14B1 any time after they reach age of majority

* Patients with a known or suspected neoplasm that occurs in the pediatric, adolescent or young adult populations are eligible for enrollment as follows:

* All cancer cases with an International Classification of Diseases for Oncology (ICD-O) histologic behavior code of one "1" (borderline), two "2" (carcinoma in situ) or three "3" (malignant)

* All neoplastic lesions of the central nervous system regardless of behavior, i.e., benign, borderline or malignant

* All neoplastic lesions of the kidney regardless of behavior, i.e., benign, borderline or malignant

* The following other benign/borderline conditions:

* Mesoblastic nephroma

* Teratomas (mature and immature types)

* Myeloproliferative diseases including transient myeloproliferative disease

* Langerhans cell histiocytosis

* Lymphoproliferative diseases

* Desmoid tumors

* Gonadal stromal cell tumors

* Neuroendocrine tumors including pheochromocytoma

* Melanocytic tumors, except clearly benign nevi

* Ganglioneuromas

* Subjects must be =\< 25 years of age at time of original diagnosis, except for patients who are being screened specifically for eligibility onto a COG (or COG participating National Clinical Trials Network \[NCTN\]) therapeutic study, for which there is a higher upper age limit

* All patients or their parents or legally authorized representatives must sign a written informed consent and agree to participate in at least one component of the study; parents will be asked to sign a separate consent for their own biospecimen submission

* If patients or their parents or legally authorized representatives have not signed the Part A subject consent form at the time of a diagnostic bone marrow procedure, it is recommended that they initially provide consent for drawing extra bone marrow using the Consent for Collection of Additional Bone Marrow; consent using the Part A subject consent form must be provided prior to any other procedures for eligibility screening or banking under APEC14B1

Dates on the record

Started 3 November 2015
Estimated completion 31 December 2030
Registry last updated 25 August 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 25 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.